
MACH32
Life-saving products that treat major trauma when and where it happens.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Support Program | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | - | (39 %) |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
MACH32 is an Edmonton-based startup specializing in the development of innovative medical devices aimed at addressing life-threatening scenarios. The company focuses on creating niche solutions to significant healthcare challenges, such as controlling airborne COVID-19 particles and managing postpartum hemorrhage in developing nations. MACH32's product line includes engineered aerosol containment devices and trauma care tools designed for pre-hospital environments. The business serves healthcare providers, military medics, and emergency responders, operating primarily in the medical device market. MACH32 generates revenue through the sale of its proprietary medical devices, leveraging Canadian-based engineering and manufacturing facilities to ensure high-quality production. The company's business model revolves around providing reliable, functional, and life-saving tools that can be rapidly deployed in urgent situations.
Keywords: medical devices, trauma care, aerosol containment, COVID-19, postpartum hemorrhage, emergency response, healthcare innovation, Canadian engineering, pre-hospital care, life-saving tools.